Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amphastar Pharmaceuticals (AMPH) Accumulated Depreciation (2016 - 2026)

Amphastar Pharmaceuticals has reported Accumulated Depreciation over the past 13 years, most recently at $306.3 million for Q4 2025.

  • For Q4 2025, Accumulated Depreciation rose 12.77% year-over-year to $306.3 million; the TTM value through Dec 2025 reached $306.3 million, up 12.77%, while the annual FY2025 figure was $306.3 million, 12.77% up from the prior year.
  • Accumulated Depreciation for Q4 2025 was $306.3 million at Amphastar Pharmaceuticals, up from $298.3 million in the prior quarter.
  • Over five years, Accumulated Depreciation peaked at $306.3 million in Q4 2025 and troughed at $189.2 million in Q1 2021.
  • A 5-year average of $239.4 million and a median of $235.1 million in 2023 define the central range for Accumulated Depreciation.
  • Biggest five-year swings in Accumulated Depreciation: increased 6.6% in 2022 and later grew 12.77% in 2025.
  • Year by year, Accumulated Depreciation stood at $199.6 million in 2021, then grew by 10.22% to $220.0 million in 2022, then increased by 11.48% to $245.3 million in 2023, then increased by 10.72% to $271.6 million in 2024, then rose by 12.77% to $306.3 million in 2025.
  • Business Quant data shows Accumulated Depreciation for AMPH at $306.3 million in Q4 2025, $298.3 million in Q3 2025, and $290.5 million in Q2 2025.